KATZ BARRETT (Chief Medical Officer) sold 60K shares of VIRIDIAN THERAPEUTICS, INC.\DE on the open market
Open‑market sale worth $2.09M. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/11/2023ACC: 0000899243-23-001626
Officer· Chief Medical Officer
Since Jan 2021
-60K
Net shares
Net seller
$2.09M
Total sold
2
Open market trades
0B · 2S
6
Total transactions
60K acquired · 120K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+12.62K
Price / share
$23.03
Trade value
$290.71K
% of position
New position
1/9/2023
0.00→12.62K
Common Stock
Direct
Shares
−12.62K
Price / share
$33.04
Trade value
$417.06K
% of position
New position
1/9/2023
12.62K→0.00
Common Stock
Direct
Shares
+47.38K
Price / share
$23.03
Trade value
$1.09M
% of position
New position
1/10/2023
0.00→47.38K
Common Stock
Direct
Shares
−47.38K
Price / share
$35.30
Trade value
$1.67M
% of position
New position
1/10/2023
47.38K→0.00
Total
Net shares
+0.00
Net value
-$707.67K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/9/2023 | M · Option Exercise | +12.62K | $23.03 | $290.71K | New position | 0.00 | 12.62K |
| Common Stock Direct | 1/9/2023 | S · Sale | −12.62K | $33.04 | $417.06K | New position | 12.62K | 0.00 |
| Common Stock Direct | 1/10/2023 | M · Option Exercise | +47.38K | $23.03 | $1.09M | New position | 0.00 | 47.38K |
| Common Stock Direct | 1/10/2023 | S · Sale | −47.38K | $35.30 | $1.67M | New position | 47.38K | 0.00 |
| Total | +0.00 | -$707.67K | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
12.62K shares
Shares
−12.62K
Strike price
23.03
Held after
343.38K
Exercisable
—
1/9/2023
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
47.38K shares
Shares
−47.38K
Strike price
23.03
Held after
296K
Exercisable
—
1/10/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock12.62K shares | 1/9/2023 | M · Option Exercise | −12.62K | 23.03 | — | 343.38K |
| Stock Option (Right to Buy) Direct | Common Stock47.38K shares | 1/10/2023 | M · Option Exercise | −47.38K | 23.03 | — | 296K |